FDA Defends Decision to Approve AcelRx’s Potent New Opioid

November 6, 2018

A powerful new opioid won Food and Drug Administration (FDA) approval on Nov. 2 after lawmakers and an FDA adviser appealed for the agency to reject it, citing concerns related to potential abuse.

Related Stories